Safety and BNT162b2 mRNA COVID-19 vaccination

Main Article Content

Beuy Joob
Viroj Wiwanitkit


safety, covid, vaccine




Download data is not yet available.
Abstract 218 | PDF Downloads 135


1. Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, Odone A, Signorelli C, Moro M. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed [Internet]. 2021 Oct. 1 [cited 2021 Oct. 4];92(S6):e2021450.
2. Mishra S, Mungmunpuntipantip I. Editorial: a good case report that might not be accepted for publication in a journal. Case Study Case Rep. 2021; 11(3): 32 - 33.